Show
Sort by
-
- Journal Article
- A1
- open access
The architecture of circulating immune cells Is dysregulated in people living with HIV on long term antiretroviral treatment and relates with markers of the HIV-1 reservoir, cytomegalovirus, and microbial tanslocation
-
- Journal Article
- A1
- open access
Motivations, barriers and experiences of participants in an HIV reservoir trial
-
- Journal Article
- A1
- open access
Measuring proviral HIV-1 DNA : hurdles and improvements to an assay monitoring integration events utilising human alu repeat sequences
-
In-vitro viral suppressive capacity correlates with immune checkpoint marker expression on peripheral CD8+ T cells in treated HIV-positive patients
-
- Journal Article
- A1
- open access
Switching from a protease inhibitor-based regimen to a dolutegravir-based regimen : a randomized clinical trial to determine the effect on peripheral blood and ileum biopsies from antiretroviral therapy-suppressed human immunodeficiency virus-infected individuals
-
- Miscellaneous
- open access
Highlights from the HIV Cure and Reservoir Symposium, 11-12 September 2017, Ghent, Belgium
-
- Journal Article
- A1
- open access
HIV reservoir characterization symposium 19 September 2016, Ghent, Belgium
-
Modeling HIV-1 latency in primary T cells using a replication-competent virus
-
The long lasting impact of early treatment initiation on the size and dynamics of HIV-1 reservoirs
(2016) -
- Journal Article
- A1
- open access
Impact of a decade of successful antiretroviral therapy initiated at HIV-1 seroconversion on blood and mucosal reservoirs